176 related articles for article (PubMed ID: 1975737)
1. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
Astbury C; Taggart AJ; Juby L; Zebouni L; Bird HA
Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737
[TBL] [Abstract][Full Text] [Related]
2. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.
Farr M; Brodrick A; Bacon PA
Rheumatol Int; 1985; 5(6):247-51. PubMed ID: 2906452
[TBL] [Abstract][Full Text] [Related]
3. Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease.
Day JM; Houston JB
Br J Clin Pharmacol; 1980 Jan; 9(1):91-4. PubMed ID: 6101957
[No Abstract] [Full Text] [Related]
4. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.
Cowan GO; Das KM; Eastwood MA
Br Med J; 1977 Oct; 2(6094):1057-9. PubMed ID: 21720
[TBL] [Abstract][Full Text] [Related]
5. Lack of interaction between sulphasalazine and cimetidine in patients with rheumatoid arthritis.
Pirmohamed M; Coleman MD; Galvani D; Bucknall RC; Breckenridge AM; Park BK
Br J Rheumatol; 1993 Mar; 32(3):222-6. PubMed ID: 8095423
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
[TBL] [Abstract][Full Text] [Related]
7. Which component of sulphasalazine is active in rheumatoid arthritis?
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
[TBL] [Abstract][Full Text] [Related]
8. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation.
Esbjörner E; Järnerot G; Wranne L
Acta Paediatr Scand; 1987 Jan; 76(1):137-42. PubMed ID: 2882643
[TBL] [Abstract][Full Text] [Related]
9. Disposition of metronidazole and its effects on sulphasalazine metabolism in patients with inflammatory bowel disease.
Shaffer JL; Kershaw A; Houston JB
Br J Clin Pharmacol; 1986 Apr; 21(4):431-5. PubMed ID: 2871853
[TBL] [Abstract][Full Text] [Related]
10. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
Pullar T; Hunter JA; Capell HA
Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
[TBL] [Abstract][Full Text] [Related]
11. [Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].
Eitner K; Reinicke C; Hippius M
Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):282-8. PubMed ID: 6151895
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.
Allgayer H; Kruis W; Eisenburg J; Paumgartner G
Eur J Clin Pharmacol; 1984; 26(2):275-7. PubMed ID: 6144549
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of sulphasalazine.
Das KM; Dubin R
Clin Pharmacokinet; 1976; 1(6):406-25. PubMed ID: 15752
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis.
Taggart AJ; McDermott B; Delargy M; Elborn S; Forbes J; Roberts SD; Ahnfelt NO
Scand J Rheumatol Suppl; 1987; 64():29-36. PubMed ID: 2893450
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
Klotz U
Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
[TBL] [Abstract][Full Text] [Related]
16. Sulphasalazine-induced leucopenia in a patient with renal dysfunction.
Teshima D; Hino B; Makino K; Yano T; Itoh Y; Joh Y; Iida M; Oishi R
J Clin Pharm Ther; 2003 Jun; 28(3):239-42. PubMed ID: 12795783
[TBL] [Abstract][Full Text] [Related]
17. Sulphasalazine treatment during breast feeding.
Järnerot G; Into-Malmberg MB
Scand J Gastroenterol; 1979; 14(7):869-71. PubMed ID: 44005
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis.
Azad Khan AK; Truelove SC
Gut; 1980 Aug; 21(8):706-10. PubMed ID: 6107264
[TBL] [Abstract][Full Text] [Related]
19. Side effects of sulphasalazine in patients with rheumatic diseases or inflammatory bowel disease.
Laasila K; Leirisalo-Repo M
Scand J Rheumatol; 1994; 23(6):338-40. PubMed ID: 7801059
[TBL] [Abstract][Full Text] [Related]
20. The effect of rifampicin on sulphapyridine plasma concentrations following sulphasalazine administration.
Shaffer JL; Houston JB
Br J Clin Pharmacol; 1985 Apr; 19(4):526-8. PubMed ID: 2859874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
